register

News & Trends - Pharmaceuticals

GSK and Pfizer’s plans for joint consumer healthcare IPO

Health Industry Hub | January 20, 2020 |

Pfizer is planning an initial public offering (IPO) of its consumer-health joint venture with GlaxoSmithKline in 3-4 years, as the two drugmakers are looking to focus on drug development in the immediate future.

The world’s biggest supplier of over-the-counter (OTC) medicines will be one of the industry’s only standalones, facing off with companies integrated into larger entities such as Johnson & Johnson, Bayer and Procter & Gamble.

With annual sales of about $13 billion, it brings under one roof Advil painkillers, Sensodyne toothpaste and Nicorette gum.

Both Glaxo, the majority owner, and Pfizer, which has about a third of the business, are looking to focus on the research and development of innovative medicines.

Recent shifts in the healthcare business and in the broader economy have challenged the pharmaceutical innovation model. Big pharma companies are increasingly focused on developing high-priced new medicines that draw on cutting-edge research in genetics and oncology.

On the consumer-health front, online price competition and pharmacy own brands have dented margins. Both GSK and Pfizer want the consumer business to focus on integration and growing sales in the short-term, not a spinoff or IPO.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

Enhance your business visibility, optimise reach and differentiate your brand. Health Industry Hub is the only one-stop-hub connecting your business to Australia’s Pharma, MedTech, and Biotech industry professionals. Get started with our unique media solutions.


News & Trends - MedTech & Diagnostics

Parliament passes lung cancer legislation

Parliament passes lung cancer legislation

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Lung cancer is the leading cause of cancer death and is responsible for almost one in […]

More


News & Trends - Pharmaceuticals

Senator Ruston criticises Budget's lack of 'real seamanship' in tackling pressing healthcare challenges

Senator Ruston criticises Budget’s lack of ‘real seamanship’ in tackling pressing healthcare challenges

Health Industry Hub | May 17, 2024 |

Pharma News: Senator Anne Ruston, Shadow Health Minister, was warmly welcomed at the Post-Budget event held in Parliament House yesterday […]

More


News & Trends - MedTech & Diagnostics

Baxter announces branding for spin-off kidney care business

Baxter announces branding for spin-off kidney care business

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Baxter has unveiled the mission and logo for its forthcoming kidney care and acute therapies company, […]

More


ESG

Health and climate strategy: All talk, no budget

Health and climate strategy: All talk, no budget

Health Industry Hub | May 16, 2024 |

ESG: The Federal Budget has sparked disappointment among health professionals for its lack of attention to addressing the escalating impacts […]

More


This content is copyright protected. Please subscribe to gain access.